Long Dollar position is markets’ ‘last man standing,’ Gallagher says

Raffaella Tenconi, chief economist and founder at ADA Economics, discusses politics in Italy, its impact on Italy’s economy and losing its investment grade status. She speaks on “Bloomberg Markets: European Open."

Life as a prostitute: Author Emma Becker on working in a brothel to research novel

Abhijit Banerjee and Esther Duflo of the Massachusetts Institute of Technology and Michael Kremer of Harvard University were awarded the 2019 Nobel Prize in Economics “for their experimental approach to alleviating global poverty.” Randall Kroszner, Chicago Booth School of Business deputy dean and former Federal Reserve governor, reacts to the announcement on "Bloomberg Surveillance."

She's one of the most respected scientists living and working in Africa today. Dr Tebello Nyokong has been awarded South Africa's highest honour, and has received accolades from the African Union and UNESCO for her research into photodynamic therapy and how it can be used to kill cancerous cells without harming any healthy ones. She spoke to us from Johannesburg for Perspective.

Pharmaceuticals are often developed over a long period of time, and can sometimes deliver unexpected effects — as with aspirin and Viagra. Researchers have now used a drug database to discover new anti-cancer substances.

A new HIV treatment, injected every eight weeks, is supposed to reduce stigma and discrimination in Uganda. The drug could be a breakthrough for all those infected — if African leaders are ready to invest.

Genomics research company 54Gene's COVID-19 testing support fund was launched today to increase Nigeria's daily testing capacity. The firm opened the fund with a donation of $150 thousand and has since received an additional $350 thousand from Union Bank. CEO of 54 Gene Abasi Ene-Obong joins CNBC Africa for more.

Coronavirus lockdowns have been touted on social media as helping to fight climate change. But in the Arctic Circle the virus is disrupting climate science. It could leave important gaps in our understanding.

The economic impact of COVID-19 has hit the world economy like a freight train. The aftereffects may be felt for years. But comparisons with World War II should give as much cause for hope as despair.

As the world continues to deal with the effects and impact of several labs and scientists are racing to develop vaccines and drugs for the cure of the novel disease. At the moment, the World Health Organization (WHO) is yet to approve any vaccine or drug for COVID-19, but different investigatory treatments and drugs are being subjected to trials. Here the are top 10 under investigation.

The Lancet paper that halted global trials of hydroxychloroquine for Covid-19 because of fears of increased deaths has been retracted after a Guardian investigation found inconsistencies in the data.

What's been agreed for the EU's seven-year budget? On the outside, it may look good for green policies, but many climate activists aren't pleased because the budget has actually slashed funding for climate action. There are shrinking budgets elsewhere too, in both healthcare and research programmes – leading some to say that Europe will lose its competitive edge when it comes to innovation. We take a closer look.